• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Persian PRISMA-7 Validated for Screening Disability Risk in Older Adults

by
November 7, 2026
in Health
Reading Time: 3 mins read
0
Persian PRISMA-7 Validated for Screening Disability Risk in Older Adults

Persian PRISMA-7 Validated for Screening Disability Risk in Older Adults

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A cross-sectional methodological study reports that a cross-culturally adapted Persian version of the PRISMA-7 screening instrument is a valid, reliable, and diagnostically accurate tool for identifying disability risk among community-dwelling older adults in Iran. Conducted by researchers Masoud Gharib, Abdolhakim Jorbonyan, and Vahid Rashedi, the investigation evaluated whether the adapted questionnaire provides sound measurement properties in this population. The evaluation demonstrated that the Persian PRISMA-7 possesses a single-factor structure, high diagnostic accuracy, good internal consistency, and excellent test-retest reliability for detecting individuals at risk of functional disability.

The investigators noted that rapid population aging has expanded the necessity for brief, validated instruments that can efficiently screen older individuals who may be at risk of disability. Although the PRISMA-7 is already widely used internationally as a screening instrument, the authors highlighted that no validated Persian version was available for healthcare providers and researchers in Iran. In response to this gap, the study was undertaken to cross-culturally adapt the questionnaire into Persian and to assess its comprehensive psychometric properties among community-dwelling older adults.

The cross-sectional methodological investigation was conducted between October 2025 and January 2026 in the city of Sari, Iran. To assemble the sample, the researchers recruited older individuals from five distinct primary healthcare centers across the study area using a systematic two-stage random sampling procedure. In total, 165 community-dwelling older adults aged 60 years or older were enrolled in the evaluation. The study participants had a mean chronological age of 70.3 years, accompanied by a standard deviation of 8.9 years, and female older adults represented 58.8 percent of the overall study cohort.

The initial phase of the research centered on the linguistic translation and cultural adaptation of the instrument, following the standardized multi-step guidelines established by Beaton. After completing this adaptation, the investigators conducted a comprehensive psychometric assessment to evaluate the measurement properties of the Persian questionnaire. Face validity and content validity were appraised using both the content validity ratio and the content validity index. Construct validity was examined through confirmatory factor analysis to verify structural consistency. Concurrent validity was tested by assessing correlation coefficients between the Persian PRISMA-7 and four established clinical assessment scales: the Barthel Index, the Katz Activities of Daily Living scale, the Lawton Instrumental Activities of Daily Living scale, and the Abbreviated Mental Test score. Finally, the researchers evaluated internal consistency, test-retest reliability, and diagnostic accuracy.

The results showed strong measurement validity for the adapted instrument, with a scale-level content validity index of 0.94 and individual item content validity ratios spanning from 0.60 to 1.00. Confirmatory factor analysis supported a single-factor structure that met standard criteria for good model fit, yielding a chi-square to degrees of freedom ratio of 1.43, a root mean square error of approximation of 0.051, a comparative fit index of 0.94, a Tucker-Lewis index of 0.92, and a standardized root mean square residual of 0.047. Furthermore, concurrent validity assessments documented statistically significant negative correlations between the screening tool and all four functional instruments. The Persian PRISMA-7 correlated with the Barthel Index at r = −0.62, the Katz Activities of Daily Living scale at r = −0.59, the Lawton Instrumental Activities of Daily Living scale at r = −0.54, and the Abbreviated Mental Test score at r = −0.48, with every association reaching statistical significance at p < 0.001.

In the reliability evaluations, the Persian PRISMA-7 demonstrated good internal consistency, as evidenced by a Cronbach’s alpha coefficient of 0.81, alongside excellent test-retest reliability across repeated administrations, reflected by an intraclass correlation coefficient of 0.89. The diagnostic accuracy of the screening questionnaire was examined using receiver operating characteristic curve analysis against a clinical benchmark of a Barthel Index score of 90 or below. This analysis demonstrated high overall diagnostic accuracy, yielding an area under the curve of 0.89. When using an optimal diagnostic cut-off score of 3 or higher, the tool yielded an 84.4 percent sensitivity and an 81.2 percent specificity. The study authors concluded that the Persian PRISMA-7 serves as a valid, reliable, and diagnostically accurate instrument for screening disability risk among older adults in Iran, emphasizing that its brevity and sound psychometric qualities justify its broader implementation across both routine clinical practice and community-based health settings.

Subject of Research: Validation of the Persian PRISMA-7 for disability risk screening in older adults

Article Title: Psychometric evaluation of the Persian PRISMA-7 for disability screening among older adults in Iran

Article References: Gharib, M., Jorbonyan, A., & Rashedi, V. (2026). Psychometric evaluation of the Persian PRISMA-7 for disability screening among older adults in Iran. BMC Geriatrics. https://doi.org/10.1186/s12877-026-08672-4

Image Credits: AI Generated

DOI: 10.1186/s12877-026-08672-4

Keywords: PRISMA-7, disability screening, older adults, psychometrics, geriatrics, Iran, cross-sectional study, validity, Psychometric, evaluation, Persian, disability

News Source: Ophelia Keating. (November 7, 2026). Persian PRISMA-7 Validated for Screening Disability Risk in Older Adults. Scienmag.

Tags: Cross-sectional Studydisabilitydisability screeningevaluationgeriatricsIranolder adultsPersianPRISMA-7psychometricpsychometricsvalidity
Share12Tweet7Share2ShareShareShare1

Related Posts

Italian Regional Study Links Mental Health Disparities to Behavioral and ESG Factors

Italian Regional Study Links Mental Health Disparities to Behavioral and ESG Factors

November 19, 2026
Digital Emergency Care Routing Diverted Acute Visits but Showed Demographic Approval Disparities

Digital Emergency Care Routing Diverted Acute Visits but Showed Demographic Approval Disparities

November 19, 2026

Novel GATA3 Frameshift Mutation Reveals Shared Hearing Profile Across Family Generations

November 19, 2026

Pakistani family study reveals wide symptom range in rare NCF4 disorder

November 19, 2026

POPULAR NEWS

  • Engineered CAR Natural Killer Cells Target Mesothelin in Ovarian Cancer Models

    Engineered CAR Natural Killer Cells Target Mesothelin in Ovarian Cancer Models

    29 shares
    Share 12 Tweet 7
  • Industrial Winemaking Enzyme Cocktail Enables High Efficiency Genetic Transformation in Medicinal Mushrooms

    29 shares
    Share 12 Tweet 7
  • Infantile Case Report Links Novel NAXE Gene Variant to Fatal Encephalopathy

    29 shares
    Share 12 Tweet 7
  • Inherited Genetic Variants Significantly Shape Glioma Risk and Tumor Biology

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Italian Regional Study Links Mental Health Disparities to Behavioral and ESG Factors

Digital Emergency Care Routing Diverted Acute Visits but Showed Demographic Approval Disparities

Novel GATA3 Frameshift Mutation Reveals Shared Hearing Profile Across Family Generations

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.